| 摘要 |
<p>The present invention discloses novel compounds of Formula (I) or pharmaceutically acceptable salts thereof which have histamine-H3 receptor antagonist or inverse agonist activity, as well as methods and intermediates for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of using these compositions to treat obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases.</p> |
| 申请人 |
ELI LILLY AND COMPANY;HIPSKIND, PHILIP, ARTHUR;TAKAKUWA, TAKAKO;JESUDASON, CYNTHIA, DARSHINI;GADSKI, ROBERT, ALAN;HORNBACK, WILLIAM, JOSEPH;PICKARD, RICHARD, TODD;BEAVERS, LISA, SELSAM |
发明人 |
HIPSKIND, PHILIP, ARTHUR;TAKAKUWA, TAKAKO;JESUDASON, CYNTHIA, DARSHINI;GADSKI, ROBERT, ALAN;HORNBACK, WILLIAM, JOSEPH;PICKARD, RICHARD, TODD;BEAVERS, LISA, SELSAM |
